Susceptibility of mice to experimental staphylococcal pyelonephritis after treatment with mercaptomerin, hydrochlorothiazide or acetazolamide.
D000086:Acetazolamide / Q000494:pharmacology*; D000818:Animals; D006852:Hydrochlorothiazide / Q000494:pharmacology*; D051379:Mice; D009941:Organomercury Compounds / Q000494:pharmacology*; D011704:Pyelonephritis / Q000276:immunology*; D013203:Staphylococcal Infections / Q000276:immunology*
D009941:Organomercury Compounds; D006852:Hydrochlorothiazide; D000086:Acetazolamide